- Home
- LXU vs MAZE Comparison
LXU vs MAZE Comparison
Compare LXU & MAZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXU
- MAZE
- Stock Information
- Founded
- LXU 1968
- MAZE 2018
- Country
- LXU United States
- MAZE United States
- Employees
- LXU N/A
- MAZE N/A
- Industry
- LXU Major Chemicals
- MAZE
- Sector
- LXU Industrials
- MAZE
- Exchange
- LXU Nasdaq
- MAZE NYSE
- Market Cap
- LXU 494.2M
- MAZE 523.1M
- IPO Year
- LXU 1969
- MAZE 2025
- Fundamental
- Price
- LXU $6.57
- MAZE $10.37
- Analyst Decision
- LXU Strong Buy
- MAZE Strong Buy
- Analyst Count
- LXU 4
- MAZE 3
- Target Price
- LXU $10.75
- MAZE $25.67
- AVG Volume (30 Days)
- LXU 355.9K
- MAZE 318.8K
- Earning Date
- LXU 04-28-2025
- MAZE 01-01-0001
- Dividend Yield
- LXU N/A
- MAZE N/A
- EPS Growth
- LXU N/A
- MAZE N/A
- EPS
- LXU N/A
- MAZE 1.25
- Revenue
- LXU $522,400,000.00
- MAZE $167,500,000.00
- Revenue This Year
- LXU $7.34
- MAZE N/A
- Revenue Next Year
- LXU $5.76
- MAZE N/A
- P/E Ratio
- LXU N/A
- MAZE $8.28
- Revenue Growth
- LXU N/A
- MAZE N/A
- 52 Week Low
- LXU $6.37
- MAZE $9.50
- 52 Week High
- LXU $10.40
- MAZE $17.00
- Technical
- Relative Strength Index (RSI)
- LXU 35.17
- MAZE N/A
- Support Level
- LXU $6.73
- MAZE N/A
- Resistance Level
- LXU $6.66
- MAZE N/A
- Average True Range (ATR)
- LXU 0.23
- MAZE 0.00
- MACD
- LXU -0.02
- MAZE 0.00
- Stochastic Oscillator
- LXU 19.31
- MAZE 0.00
About LXU LSB Industries Inc.
LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.
About MAZE MAZE THERAPEUTICS INC
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.